Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Philipp Rechtsteiner"'
Autor:
Matthias Düchs, Dragica Blazevic, Philipp Rechtsteiner, Cynthia Kenny, Thorsten Lamla, Sarah Low, Jimmy Savistchenko, Manuela Neumann, Ronald Melki, Tanja Schönberger, Birgit Stierstorfer, David Wyatt, Frederik Igney, Thomas Ciossek
Publikováno v:
npj Parkinson's Disease, Vol 9, Iss 1, Pp 1-15 (2023)
Abstract Prion-like transmission of pathology in α-synucleinopathies like Parkinson’s disease or multiple system atrophy is increasingly recognized as one potential mechanism to address disease progression. Active and passive immunotherapies targe
Externí odkaz:
https://doaj.org/article/bfa18d4f4cb54bf398d1a6ddf489f5be
Autor:
Matthias Düchs, Dragica Blazevic, Philipp Rechtsteiner, Cynthia Kenny, Thorsten Lamla, Sarah Low, Jimmy Savistchenko, Manuela Neumann, Ronald Melki, Tanja Schönberger, Birgit Stierstorfer, David Wyatt, Frederik Igney, Thomas Ciossek
Prion-like transmission of pathology in α-synucleinopathies like Parkinson’s disease or multiple system atrophy is increasingly recognized as one potential mechanism to address disease progression. Active and passive immunotherapies targeting inso
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::8926442dadbf8f2667aede74b3b6140c
https://doi.org/10.1101/2022.11.30.518485
https://doi.org/10.1101/2022.11.30.518485
Autor:
Matthias J. Düchs, Katja S. Baum-Kroker, Sebastian Kreuz, Dirk Gottschling, Clemens Braun, Bernhard Schmid, Philipp Rechtsteiner, Benjamin Strobel, Dragica Blazevic, Thomas Ciossek, Jörg S. Hartig
Publikováno v:
ACS synthetic biology. 9(6)
Adeno-associated viral (AAV) vector-mediated gene therapy holds great potential for future medical applications. However, to facilitate safer and broader applicability and to enable patient-centric care, therapeutic protein expression should be contr
Autor:
Gudrun Zimmermann, Philipp Rechtsteiner, Benjamin Strobel, Thorsten Lamla, Christine Mayer, Sebastian Kreuz, Kai Zuckschwerdt, Ruth Eytner
Publikováno v:
Human Gene Therapy Methods
Adeno-associated virus (AAV) vectors currently represent the most attractive platform for viral gene therapy and are also valuable research tools to study gene function or establish disease models. Consequently, many academic labs, core facilities, a